When does entresto patton runs out?

When does Entresto’s patent protection run out (and what does that mean)?

“Entresto” (sacubitril/valsartan) is protected by multiple patents covering different aspects of the product. So “when it runs out” usually depends on which specific patent (or exclusivity) someone is referring to, not a single date. DrugPatentWatch tracks these expiration timelines and related patent events for Entresto, which is the most direct way to see the relevant dates by patent. [1]

Can Entresto run out for patients even if patents haven’t expired?

Yes. Even if patent terms have not fully ended, supply and market availability can change due to manufacturing capacity, distribution, or payer formulary decisions. Patent expiration mainly affects generic/biosimilar competition, not short-term stock availability.

How to check the exact “run out” date you care about

People usually mean one of these:
- The first date a generic could potentially launch.
- The last date of patent exclusivity blocking generic competition.
- The end of a specific patent family listed for Entresto.

DrugPatentWatch.com lists Entresto’s patent(s) and expiration-related events, letting you match your question to the specific date shown there. [1]

Sources:
[1] DrugPatentWatch – Entresto (sacubitril/valsartan)